-
Je něco špatně v tomto záznamu ?
Shared structural features of the 9aaTAD family in complex with CBP
M. Piskacek, A. Vasku, R. Hajek, A. Knight,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT14310
MZ0
CEP - Centrální evidence projektů
PubMed
25564305
DOI
10.1039/c4mb00672k
Knihovny.cz E-zdroje
- MeSH
- aminokyselinové motivy MeSH
- databáze proteinů MeSH
- forkhead transkripční faktory chemie metabolismus MeSH
- interakční proteinové domény a motivy * MeSH
- molekulární konformace * MeSH
- molekulární modely * MeSH
- nádorový supresorový protein p53 chemie metabolismus MeSH
- protein vázající CREB chemie metabolismus MeSH
- protoonkogenní protein MLL chemie MeSH
- sekvence aminokyselin MeSH
- transkripční faktory chemie metabolismus MeSH
- vazba proteinů MeSH
- vazebná místa MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
A number of transactivation domains for transcription factors including p53, E2A/HEB, MLL, cMyb, CREB, FOXO3, Gcn4, Oaf1 and Pdr1 have been reported to interact with the KIX domain of general transcriptional mediators CBP, p300 or MED15. Most of those factors belong to the already established Nine amino acid Transactivation Domain (9aaTAD) family. By using available structural data, we found binding analogy for the 9aaTAD in the MLL-KIX and also E2A/HEB-KIX complexes. We recognized two distinct TAD formations in the KIX complex. In the E2A/HEB-KIX complex, the leucine position is determined by the prolonged helical structure including the 9aaTAD and the leucine (long-helical TAD). However in the MLL-KIX complex, the equal position of 9aaTAD and proximal leucine is achieved differently by leucine-turn-helix structural architecture. Furthermore, the FOXO3-KIX complex shares structural analogy with the E2A-KIX complex in respect of both 9aaTAD and proximal leucine. Next, from (i) sequence alignment of the identified 9aaTADs in p53, E2A/HEB and MLL proteins and (ii) the resolved structure of the MLL-KIX and E2A/HEB-KIX complexes, we generated a plausible structural model for p53 that could be used also for other members of the 9aaTAD family. The position of 9aaTADs in Oaf1-, Pdr1- and Gcn4-MED15 KIX complexes and 9aaTAD composition are in good agreement with E2A, MLL, FOXO3 and p53. Analyses of structural data in this study define fundamental structural requirements and shed more light on the ambiguous 9aaTAD domain.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000405
- 003
- CZ-PrNML
- 005
- 20191021101819.0
- 007
- ta
- 008
- 160108s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1039/c4mb00672k $2 doi
- 035 __
- $a (PubMed)25564305
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Piskáček, Martin $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Czech Republic. Piskacek@med.muni.cz. $7 xx0213400
- 245 10
- $a Shared structural features of the 9aaTAD family in complex with CBP / $c M. Piskacek, A. Vasku, R. Hajek, A. Knight,
- 520 9_
- $a A number of transactivation domains for transcription factors including p53, E2A/HEB, MLL, cMyb, CREB, FOXO3, Gcn4, Oaf1 and Pdr1 have been reported to interact with the KIX domain of general transcriptional mediators CBP, p300 or MED15. Most of those factors belong to the already established Nine amino acid Transactivation Domain (9aaTAD) family. By using available structural data, we found binding analogy for the 9aaTAD in the MLL-KIX and also E2A/HEB-KIX complexes. We recognized two distinct TAD formations in the KIX complex. In the E2A/HEB-KIX complex, the leucine position is determined by the prolonged helical structure including the 9aaTAD and the leucine (long-helical TAD). However in the MLL-KIX complex, the equal position of 9aaTAD and proximal leucine is achieved differently by leucine-turn-helix structural architecture. Furthermore, the FOXO3-KIX complex shares structural analogy with the E2A-KIX complex in respect of both 9aaTAD and proximal leucine. Next, from (i) sequence alignment of the identified 9aaTADs in p53, E2A/HEB and MLL proteins and (ii) the resolved structure of the MLL-KIX and E2A/HEB-KIX complexes, we generated a plausible structural model for p53 that could be used also for other members of the 9aaTAD family. The position of 9aaTADs in Oaf1-, Pdr1- and Gcn4-MED15 KIX complexes and 9aaTAD composition are in good agreement with E2A, MLL, FOXO3 and p53. Analyses of structural data in this study define fundamental structural requirements and shed more light on the ambiguous 9aaTAD domain.
- 650 _2
- $a aminokyselinové motivy $7 D020816
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a protein vázající CREB $x chemie $x metabolismus $7 D050882
- 650 _2
- $a databáze proteinů $7 D030562
- 650 _2
- $a forkhead transkripční faktory $x chemie $x metabolismus $7 D051858
- 650 12
- $a molekulární modely $7 D008958
- 650 12
- $a molekulární konformace $7 D008968
- 650 _2
- $a protoonkogenní protein MLL $x chemie $7 D051788
- 650 _2
- $a vazba proteinů $7 D011485
- 650 12
- $a interakční proteinové domény a motivy $7 D054730
- 650 _2
- $a transkripční faktory $x chemie $x metabolismus $7 D014157
- 650 _2
- $a nádorový supresorový protein p53 $x chemie $x metabolismus $7 D016159
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vašků, Anna, $d 1954- $7 mzk2006356130
- 700 1_
- $a Hajek, Roman
- 700 1_
- $a Knight, Andrea
- 773 0_
- $w MED00169253 $t Molecular bioSystems $x 1742-2051 $g Roč. 11, č. 3 (2015), s. 844-551
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25564305 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20191021102252 $b ABA008
- 999 __
- $a ok $b bmc $g 1102686 $s 924611
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 11 $c 3 $d 844-551 $e 20150107 $i 1742-2051 $m Molecular bioSystems $n Mol Biosyst $x MED00169253
- GRA __
- $a NT14310 $p MZ0
- LZP __
- $a Pubmed-20160108